October 22, 2021

Dr. Johns interviewed by Healio

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.

READ THE HEALIO ARTICLE
The Latest
Association between Trust of Researchers and Willingness to Participate in Alzheimer’s Disease Biomarker Research
Influence

Association between Trust of Researchers and Willingness to Participate in Alzheimer’s Disease Biomarker Research

NEXT STEPs conference at Regenstrief Institute educates audience about including nursing home residents in clinical trials
News

NEXT STEPs conference at Regenstrief Institute educates audience about including nursing home residents in clinical trials

Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States
Influence

Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States

Association between Trust of Researchers and Willingness to Participate in Alzheimer’s Disease Biomarker Research
Influence

Association between Trust of Researchers and Willingness to Participate in Alzheimer’s Disease Biomarker Research

Renowned delirium researcher and clinician named Regenstrief interim center director
News

Renowned delirium researcher and clinician named Regenstrief interim center director

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation
News

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation